More recently, genome-wide association studies (GWAS) have revealed a set of single-nucleotide polymorphisms (SNPs) associated with BC risk in non- selected BC patients20 (BC susceptibility factors), but also in sub-cohorts such as BRCA1 mutation carriers21 (and therefore called genetic modifiers of cancer risk). The gene discussed is BRCA1; the disease is cancer.